Tr
Eng
Main Page
Corporate
Products
Links
Membership
HR
Contact
Member Login
Product Search
Choose Indication...
REVERSE ANTI-COAGULANT TREATMENT
ACTIVE IMMUNIZATION AGAINIST RABIES (Risk Groups and Post Bites)
ONCOTIC PRESSURE LOSS
VOLUME DEFICIT
HEREDITARY ANGIO OEDEMA (HAE)
ACQUIRED ANGIO OEDEMA (AAE)
ACTIVE IMMUNIZATION AGAINIST HEPATITIS A
ACTIVE IMMUNIZATION AGAINIST HEPATITIS B
PASSIVE IMMUNIZATION AGAINIST RABIES
PRIMARY AND SECONDARY IMMUNE DEFICIENCY
INFECTION PROPHYLAXIS OF DISORDERS IN THE ANTIBODY FORMATION
NEONATAL HBV PROPHYLAXIS
POST EXPOSURE WITH HBV PROPHYLAXIS
POST OKT HBV PROPHYLAXIS
INFLUENZA PROPHYLAXIS
TREATMENT AND PROPHYLAXIS OF BLEEDING IN PATIENTS WITH HAEMOPHILIA B
ALLOGENIC BONE MARROW TRANSPLANTATION
PROPHYLAXIS OF TETANUS
ACUTE TETANUS TREATMENT
ACTIVE IMMUNIZATION AGAINIST TYPHOID
Choose Efficient Clause...
PCC
Rabies Virus
Albumin
C1 Esteraze inhibutors
Hepatitis A virus-inactivated
Anti Rabies Immunoglobuline
Immunoglobuline G
Recombinant Hepatitis B antigen
Hepatitis B Immunoglobuline G
Inactive Influenza
Factor IX
Tetanus Immunoglobuline G
Typhoid (Salmonella Typhi TY21a)
Choose Product
ABHAYRAB
ABHAYRAB
CEALB
CEALB
CETOR
CETOR
COFACT
COFACT
EPAXAL
EPAXAL
EQUIRAB
EQUIRAB
G.P.O %4
G.P.O %4
GAMMAQUIN
GAMMAQUIN
HEPAVAX GENE
HEPAVAX GENE
HepBQuin I.M
HepBQuin I.M
INFLEXAL V
INFLEXAL V
NANOGAM
NANOGAM
NONAFACT
NONAFACT
OMR-IG-AM
OMR-IG-AM
OMRI-HEP-B
OMRI-HEP-B
TETAQUIN
TETAQUIN
VIVOTIF
VIVOTIF
News / Notices
Info
Virosome Technology for Vaccines
Seven Steps to Safety for Blood products
NECESSARY LINKS